脑部放疗，上午比下午敏感许多！6 Q* W- r2 }/ D! D8 W- L# j1 t& [
- B: [, e* L6 j' A+ Y# V: d# W- C& d" G- l) D! D5 N/ C, j2 P0 x$ R( h
Cancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.
7 e3 Y! \: P. E$ }( G* W) ZGamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?: {; W4 g) J \
Rahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.# N7 W* o# ?: r: s1 K# M
SourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.( Z# a" Z' Z/ o" q# K
1 V) {8 B }4 O+ c6 N
Abstract' f: v; [- D) @" B# \4 B- j
BACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.) x% D2 ?) x# z7 u- [8 C
2 P& h& [% ~7 }4 n! D, j
METHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.) g( r* G: b2 ]7 }
6 N, X3 V, v/ p% j: J7 ?! v% k: ]6 \5 |
RESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026).& z/ \, V: e5 E/ @3 v6 z9 k
! E* i, n, |8 }) Q) pCONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.5 P! R6 e& O- S6 ]
# W# j3 |0 G. X
|
显身卡
* u, M( g3 U4 M, T' R
